Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results Acq. announced Director departure CC transcript
|
ACHIEVE LIFE SCIENCES, INC. (ACHV)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/25/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/25/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
09/12/2017 |
4/A
| MOYES JAY M (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 16,400 options to buy
@ $0 |
|
09/12/2017 |
4/A
| Joseph Donald (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 16,400 options to buy
@ $0 |
|
09/12/2017 |
4/A
| PARKER H STEWART (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 11,000 options to buy
@ $0 |
|
09/12/2017 |
4/A
| MATTINGLY MARTIN A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 11,000 options to buy
@ $0 |
|
09/12/2017 |
4/A
| JACOBS CINDY (EVP, CMO) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 274,000 options to buy
@ $0 |
|
09/12/2017 |
4/A
| Cormack Scott Daniel (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 11,000 options to buy
@ $0 |
|
09/12/2017 |
4/A
| Bencich John (CFO) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 274,000 options to buy
@ $0 |
|
08/11/2017 |
4/A
| Clarke Anthony (President & CSO) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 550,455 shares
@ $0 Granted 359,305 shares
@ $0 Granted 538,958 shares
@ $0 Granted 176,418 shares
@ $0 |
|
08/11/2017 |
4/A
| Stewart Richard Alistair (Chairman & CEO) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
Txns:
| Granted 1,950,309 shares
@ $0 Granted 71,861 shares
@ $0 Granted 176,418 shares
@ $0 |
|
08/13/2014 |
4/A
| Bencich John (CFO and PFO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options to buy
@ $0 Granted 20,000 restricted stock units
@ $0 |
|
10/07/2013 |
4/A
| JACOBS CINDY (EVP, CMO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Sold 1,364 shares
@ $8.68, valued at
$11.8k
|
|
10/07/2013 |
4/A
| JACOBS CINDY (EVP, CMO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Sold 534 shares
@ $11.9, valued at
$6.4k
|
|
10/07/2013 |
4/A
| Cormack Scott Daniel (President and CEO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Sold 3,112 shares
@ $8.68, valued at
$27k
|
|
10/07/2013 |
4/A
| Cormack Scott Daniel (President and CEO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.
Txns:
| Sold 2,134 shares
@ $11.9, valued at
$25.4k
|
|
10/03/2013 |
4/A
| Wyrick Susan D. (PAO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC. |
02/03/2009 |
4/A
| Cormack Scott Daniel (President and CEO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC. |
02/02/2009 |
4/A
| JACOBS CINDY (EVP, CMO) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC. |
02/02/2009 |
4/A
| Clendeninn Neil James (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC. |
02/02/2009 |
4/A
| Anderson Stephen Charles (CFO and Secretary) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC. |
|
|